Leavitt Chase C. — SEC insider filings
SEC reporting owner CIK 1777467. 15 insider filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2021-03-17 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 5 filings — 45,000 shares, $104,305 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 3,000 shares @ $15.00 ($45,000) in Mobia Medical, Inc., filed 2026-05-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | SEE REMARKS | 2 | 2 legs · 5,000 sh · $65,600 | — | 1 |
| Oncternal Therapeutics, Inc. (ONCT) | General Counsel/Secretary | 12 | 5 legs · 40,000 sh · $38,705 | — | 18 |
| Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel/Secretary | 1 | — | — | 1 |
Insider filings — Leavitt Chase C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Mobia Medical, Inc. (MOBI) | Purchase (P): 2,000 @ $10.30 | EDGAR |
| 2026-05-11 | 4 | Mobia Medical, Inc. (MOBI) | Purchase (P): 3,000 @ $15 · Grant/award (A): 175,760 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 14,200 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Tax withholding (F): 11,838 @ $0.50 | EDGAR |
| 2023-10-04 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 55,519 (derivative) · Disposition to issuer (D): 28,750 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 65,000 (derivative) · Grant/award (A): 55,519 (derivative) · +3 more | EDGAR |
| 2023-07-05 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Tax withholding (F): 10,305 @ $0.36 | EDGAR |
| 2023-04-14 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Purchase (P): 15,000 @ $0.29 · Purchase (P): 10,000 @ $0.29 | EDGAR |
| 2023-02-23 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Tax withholding (F): 6,091 @ $1.02 | EDGAR |
| 2022-08-01 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 43,125 @ $0 · Grant/award (A): 28,750 (derivative) @ $0 | EDGAR |
| 2022-01-31 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Purchase (P): 8,500 @ $1.78 · Purchase (P): 5,000 @ $1.63 | EDGAR |
| 2022-01-24 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 55,519 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 29,867 @ $0 | EDGAR |
| 2021-06-15 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Purchase (P): 1,500 @ $5.45 | EDGAR |
| 2021-03-17 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 699,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777467 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs